A previously healthy 73-year-old man was brought to Temple University Hospital in Philadelphia, PA by family members after experiencing anorexia and persistently elevated fevers for 4 to 5 days.
The FDA approved Bizengri for adults with advanced, unresectable, or metastatic NRG1 fusion-positive cholangiocarcinoma after prior systemic therapy, providing a new targeted option for an ultra-rare and...
In this video, Kevin Bozic, MD, MBA, the Chair of the Department of Surgery and Perioperative Care at Dell Medical School at the University of Texas, Austin discusses why meaningful progress in value-based...
In this video recap, Annie Truss, MD, outlines practical strategies to evaluate high-impact disease, identifies underrecognized presentations in skin of color, and incorporates newer therapies into routine...
From medication access to adherence challenges, social vulnerability can shape diabetes outcomes. In this expert Q&A, Dr. Mary Elizabeth Patti reviews evidence showing that metabolic surgery delivers...
In the next installment of the Myelofibrosis Caregiver Interview Series, Fadi Haddad, MD, emphasizes a patient- and caregiver-centered approach to treatment planning—highlighting how clinical decisions...
A previously healthy 73-year-old man was brought to Temple University Hospital in Philadelphia, PA by family members after experiencing anorexia and persistently elevated fevers for 4 to 5 days.
Gracyn Allan, BS; Rachel Anderson, BS; Gelan Shamloul, DO; Thomas N. Helm, MD
A 19-year-old collegiate athlete presented with progressive darkening of the lips and oral mucosa beginning in the summer of 2022. The pigmentation, which began on her lips, extended over time to her...
